ASCO Daily News

134 Afleveringen

1. What the FDA CAR T-Cell Therapy Investigation Means for Oncologists

   Gepubliceerd: 7-12-2023
2. Managing the Complexities of Oncology Practice in 2024

   Gepubliceerd: 7-12-2023
3. Solutions and Key Research to Advance High-Quality Cancer Care

   Gepubliceerd: 9-11-2023
4. How to Implement Universal Germline Testing for CRC

   Gepubliceerd: 2-11-2023
5. Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy

   Gepubliceerd: 12-10-2023
6. Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer

   Gepubliceerd: 28-9-2023
7. ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care

   Gepubliceerd: 17-8-2023
8. How Oncologists Are Confronting the Cancer Drug Shortage

   Gepubliceerd: 10-8-2023
9. AI Will Allow Doctors to Reclaim Time With Patients

   Gepubliceerd: 3-8-2023
10. Managing the Side Effects of Endocrine Therapy for Breast Cancer

    Gepubliceerd: 27-7-2023
11. The Emergence of Triplet Therapies in ccRCC in the Frontline Setting

    Gepubliceerd: 13-7-2023
12. Novel Therapies in GI Oncology at ASCO23

    Gepubliceerd: 28-6-2023
13. THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23

    Gepubliceerd: 27-6-2023
14. Spotlight on Immunotherapy at ASCO23

    Gepubliceerd: 26-6-2023
15. Highlights in Hematologic Malignancies at ASCO23

    Gepubliceerd: 23-6-2023
16. ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23

    Gepubliceerd: 22-6-2023
17. SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23

    Gepubliceerd: 21-6-2023
18. Addressing the Impact of Prior Authorization on Access to Cancer Treatment

    Gepubliceerd: 8-6-2023
19. ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy

    Gepubliceerd: 25-5-2023
20. ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies

    Gepubliceerd: 25-5-2023